sandoz

Latest stories

  • in Health care

    Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma, Sandoz

    by

    Thousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in a patent infringement lawsuit against Sandoz Inc. and Zydus Pharmaceuticals (USA), Inc. The decision affirms the permanent injunction entered by the district court prohibiting Sandoz and […] More

  • in Health care

    Sandoz gets European Commission nod for Hyrimoz high-concentration formulation

    by

    Basel: Sandoz has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for a citrate-free high concentration formulation (HCF; 100 mg/mL) of its biosimilar Hyrimoz (adalimumab). The approval includes all indications covered by the reference medicine*: rheumatic diseases, Crohn’s disease, ulcerative colitis, plaque psoriasis, uveitis and hidradenitis suppurativa. “Living […] More